461 related articles for article (PubMed ID: 34854906)
41. Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study.
Ble A; Hughes PM; Delgado J; Masoli JA; Bowman K; Zirk-Sadowski J; Mujica Mota RE; Henley WE; Melzer D
J Gerontol A Biol Sci Med Sci; 2017 Feb; 72(2):243-250. PubMed ID: 27146371
[TBL] [Abstract][Full Text] [Related]
42. Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation.
Choi KH; Seo WK; Park MS; Kim JT; Chung JW; Bang OY; Kim GM; Song TJ; Kim BJ; Heo SH; Jung JM; Oh KM; Kim CK; Yu S; Park KY; Kim JM; Park JH; Choi JC; Hwang YH; Kim YJ
J Am Heart Assoc; 2019 Dec; 8(24):e013941. PubMed ID: 31826725
[TBL] [Abstract][Full Text] [Related]
43. Statins for secondary prevention and major adverse events after coronary artery bypass grafting.
Pan E; Nielsen SJ; Mennander A; Björklund E; Martinsson A; Lindgren M; Hansson EC; Pivodic A; Jeppsson A
J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1875-1886.e4. PubMed ID: 34893327
[TBL] [Abstract][Full Text] [Related]
44. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
Stam-Slob MC; Visseren FL; Wouter Jukema J; van der Graaf Y; Poulter NR; Gupta A; Sattar N; Macfarlane PW; Kearney PM; de Craen AJ; Trompet S
Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244
[TBL] [Abstract][Full Text] [Related]
45. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
46. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial.
Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP
Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005
[TBL] [Abstract][Full Text] [Related]
47. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?
Lingsma HF; Steyerberg EW; Scholte op Reimer WJ; van Domburg R; Dippel DW;
Acta Neurol Scand; 2010 Jul; 122(1):15-20. PubMed ID: 20047571
[TBL] [Abstract][Full Text] [Related]
48. Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.
Prats-Sanchez L; Camps-Renom P; Nash PS; Wilson D; Ambler G; Best JG; Guasch-Jiménez M; Ramos-Pachón A; Martinez-Domeño A; Lambea-Gil Á; Díaz GE; Guisado-Alonso D; Du H; Al-Shahi Salman R; Jäger HR; Lip GY; Ay H; Jung S; Bornstein NM; Gattringer T; Eppinger S; van Dam-Nolen DH; Koga M; Toyoda K; Fluri F; Phan TG; Srikanth VK; Heo JH; Bae HJ; Kelly PJ; Imaizumi T; Staals J; Köhler S; Yakushiji Y; Orken DN; Smith EE; Wardlaw JM; Chappell FM; Makin SD; Mas JL; Calvet D; Bordet R; Chen CP; Veltkamp R; Kandiah N; Simister RJ; De Leeuw FE; Engelter ST; Peters N; Soo YO; Zietz A; Hendrikse J; Mess WH; Werring DJ; Marti-Fabregas J;
Neurology; 2024 Apr; 102(7):e209173. PubMed ID: 38471056
[TBL] [Abstract][Full Text] [Related]
49. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
[TBL] [Abstract][Full Text] [Related]
50. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
[TBL] [Abstract][Full Text] [Related]
51. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
Vrecer M; Turk S; Drinovec J; Mrhar A
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with statin discontinuation near end of life in a Danish primary health care cohort.
Engell AE; Bathum L; Andersen JS; Thompson W; Lind BS; Jørgensen HL; Nexøe J
Fam Pract; 2023 Mar; 40(2):300-307. PubMed ID: 35950318
[TBL] [Abstract][Full Text] [Related]
53. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.
Spencer FA; Allegrone J; Goldberg RJ; Gore JM; Fox KA; Granger CB; Mehta RH; Brieger D;
Ann Intern Med; 2004 Jun; 140(11):857-66. PubMed ID: 15172899
[TBL] [Abstract][Full Text] [Related]
54. Prognosis at 6 months for coronary and cerebrovascular patients: impact of antiplatelet agents and statins: results from the Prevenir III study.
Ferrières J; Cambou JP; Cantet C; Guize L
Cardiovasc Drugs Ther; 2006 Feb; 20(1):55-61. PubMed ID: 16552472
[TBL] [Abstract][Full Text] [Related]
55. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
[TBL] [Abstract][Full Text] [Related]
56. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
[TBL] [Abstract][Full Text] [Related]
57. Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan.
Tomida J; Yoshida T; Senda S; Sato T; Nakatsuma A; Iihara N
Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):873-885. PubMed ID: 36960485
[TBL] [Abstract][Full Text] [Related]
58. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study.
Daskalopoulou SS; Delaney JA; Filion KB; Brophy JM; Mayo NE; Suissa S
Eur Heart J; 2008 Sep; 29(17):2083-91. PubMed ID: 18664465
[TBL] [Abstract][Full Text] [Related]
59. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
Nilsson G; Samuelsson E; Söderström L; Mooe T
BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
[TBL] [Abstract][Full Text] [Related]
60. Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.
Lefeber GJ; Koek HL; Souverein PC; Bouvy ML; de Boer A; Knol W
J Am Geriatr Soc; 2020 Feb; 68(2):329-336. PubMed ID: 31647578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
